Summary
Vivus, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Vivus, Inc. (Vivus or 'the company'), a subsidiary of Biopharma LLC, is a biopharmaceutical company focused on research, development, and commercialization of innovative and next-generation therapies which in turn addresses various medical needs of its patients. These products find application in cystic fibrosis, chronic pancreatitis, obesity, inflammatory bowel disease, and diabetes. Vivus's approved therapies include Qsymia and Pancreaze/Pancrease MT (pancrelipase). The company's pipeline product, Tacrolimus is being developed for the treatment of pulmonary arterial hypertension (PAH). Vivus markets its products under Qsymia and Pancreaze brand names. The company operations are spread across Australia, New Zealand, the US, and Rest of the World. The company is headquartered in Campbell, California, the US
Scope
- Detailed information on Vivus, Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vivus, Inc in the form of a SWOT analysis
- An in-depth view of the business model of Vivus, Inc including a breakdown and examination of key business segments
- Intelligence on Vivus, Inc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vivus, Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Vivus, Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vivus, Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Vivus, Inc's business structure, strategy and prospects.
'
Table of Contents
Company Snapshot
Vivus, Inc.: Company Overview
Vivus, Inc.: Overview and Key Facts
Vivus, Inc.: Overview
Vivus, Inc.: Key Facts
Vivus, Inc.: Key Employees
Vivus, Inc.: Key Employee Biographies
Vivus, Inc.: Major Products and Services
Vivus, Inc.: Company History
Vivus, Inc.: Locations and Subsidiaries
Vivus, Inc.: Key Competitors
Vivus, Inc.: Company Analysis
Vivus, Inc.: Business Description
Vivus, Inc.: SWOT Analysis
Vivus, Inc.: SWOT Overview
Vivus, Inc.: Strengths
Vivus, Inc.: Weaknesses
Vivus, Inc.: Opportunities
Vivus, Inc.: Threats
Vivus, Inc.: Corporate Financial Deals Activity
Vivus, Inc.: Financial Deals Overview
Vivus, Inc.: Top Deals 2018 - 2022YTD*
Vivus, Inc.: Advisors
Vivus, Inc.: Top Legal Advisors
Vivus, Inc.: Mergers and Acquisitions
Vivus, Inc.: Capital Raising
Vivus, Inc.: Recent Developments
Vivus, Inc.: News and Events Summary
Vivus, Inc.: Contracts
Vivus, Inc.: Corporate Governance
Vivus, Inc.: Corporate Social Responsibility
Vivus, Inc.: Financial Deals
Vivus, Inc.: Financial Performance
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Vivus, Inc.: Key Facts
Table 2: Vivus, Inc.: Key Employees
Table 3: Vivus, Inc.: Company History
Table 4: Vivus, Inc.: Locations and Subsidiaries
Table 5: Vivus, Inc.: Key Competitors
Table 6: Vivus, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 7: Vivus, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Vivus, Inc.: Top Deals 2018 - 2022YTD*
Table 9: Vivus, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Vivus, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Table 11: Vivus, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 12: Vivus, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Table 13: Vivus, Inc.: News and Events Summary
Table 14: Vivus, Inc.: Contracts
Table 15: Vivus, Inc.: Corporate Governance
Table 16: Vivus, Inc.: Corporate Social Responsibility
Table 17: Vivus, Inc.: Financial Deals
Table 18: Vivus, Inc.: Financial Performance
List of Figures
Figure 1: Vivus, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 2: Vivus, Inc.: M&A Average Deal Size - Value (US$m)
Figure 3: Vivus, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 4: Vivus, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 5: Vivus, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
